RT Journal Article
SR Electronic
T1 Non-obese lipedema patients show a distinctly altered Quantitative Sensory Testing profile with high diagnostic potential
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.25.23289086
DO 10.1101/2023.04.25.23289086
A1 Dinnendahl, Rebecca
A1 Tschimmel, Dominik
A1 Löw, Vanessa
A1 Cornely, Manuel
A1 Hucho, Tim
YR 2023
UL http://medrxiv.org/content/early/2023/11/22/2023.04.25.23289086.abstract
AB Background Lipedema is a widespread severe chronic disease affecting mostly women. Characterized by painful bilateral fat accumulation in extremities sparing hands and feet, objective measurement-based diagnosis is currently missing. We tested for characteristic psychometric and/or sensory alterations including pain and for their potential for medical routine diagnostic.Methods Pain-psychometry were assessed using the German Pain Questionnaire. Sensory sensitivity toward painful and non-painful stimuli was characterized in non-obese lipedema patients and matched controls using the validated QST-protocol of the German Research Network on Neuropathic Pain.Results Lipedema patients showed no overt psychometric abnormalities. Pain was reported as somatic rather than psychosomatic-aversive. All QST measurements were normal, but the pressure pain threshold (PPT) was twofold reduced and the vibration detection threshold (VDT) was two and a half times increased. Both thresholds were selectively altered at the affected thigh but not the unaffected hand. ROC-analysis of the combination of PPT and VDT of thigh versus hand into a PVTH-score shows high sensitivity and specificity, categorizing correctly 96.5% of the participants as lipedema patients or healthy controls. Bayesian inference analysis corroborated the diagnostic potential of a combined PVTH score.Conclusion We propose to assess PPT and VDT at the painful thigh and the pain-free hand. Combination in a PVTH-score may allow a convenient lipedema diagnosis early during disease development.Trial Registration German Clinical Trials Register (DRKS00030509)Funding The project was funded by the DFG (459479161).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Project was funded by the DFGAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of University Hospital Cologne gave ethical approval for this work. Ethics committee of the Aerztekammer Nordrhein gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.